Sugi Predict

Sugi Predict / Compounds / SCHEMBL2930481

SCHEMBL2930481

SCHEMBL2930481

CC(=O)c1c(O)cccc1OCCCCN(CCCc1ccc(N2CC(=O)NS2(=O)=O)c(O)c1)C(=O)c1c(O)cccc1OCCCCNC(=O)CCc1ccc(N2CC(=O)NS2(=O)=O)c(O)c1

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 4/20 0.39
▸ CNR2 P34972 4/20 0.39
▸ PTPN1 P18031 10/20 0.38
▸ MAPT P10636 1/20 0.32
▸ MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3201537 0.94 CNR1 (0.43) CNR1CNR2PTPN1MAPTMAOB
SCHEMBL2930479 0.91 CNR1 (0.41) CNR1CNR2PTPN1
SCHEMBL3929110 0.90 CNR1 (0.41) CNR1CNR2PTPN1MAPT
SCHEMBL3220375 0.88 PTPN1 (0.41) CNR1CNR2PTPN1MAPT
SCHEMBL3220485 0.87 PTPN1 (0.43) CNR1CNR2PTPN1
SCHEMBL3217932 0.87 CNR1 (0.41) CNR1CNR2PTPN1
SCHEMBL2933664 0.85 CNR1 (0.46) CNR1CNR2PTPN1MAPT
SCHEMBL3216067 0.85 CNR1 (0.42) CNR1CNR2PTPN1
SCHEMBL4127080 0.84 CNR1 (0.49) CNR1CNR2PTPN1MAPT
SCHEMBL2937650 0.84 PTPN1 (0.40) CNR1CNR2PTPN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227245-A2 COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS Novartis AG (CH) 2010-09-15 — — EP disclosed
WO-2009068689-A2 COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS NOVARTIS AG (CH) 2009-06-04 — — WO disclosed
WO-2008067527-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS NOVARTIS AG (CH) 2008-06-05 — — WO disclosed